Results 301 to 310 of about 14,055,650 (415)
This study investigates an alternative approach to reactivating the oncosuppressor p53 in cancer. A short peptide targeting the association of the two p53 inhibitors, MDM2 and MDM4, induces an otherwise therapeutically active p53 with unique features that promote cell death and potentially reduce toxicity towards proliferating nontumor cells.
Sonia Valentini+10 more
wiley +1 more source
Pavlovian to instrumental transfer of control over fight or flight decisions. [PDF]
Eder AB, Mitschke V.
europepmc +1 more source
IMPACTED CERUMEN AURIS MANAGEMENT: COMPARISON OF OUTCOME BETWEEN SUCTION CLEARANCE AND SYRINGING
Muhammad Ismail Khan+2 more
openalex +2 more sources
Elevated level of cholesterol is positively correlated to prostate cancer development and disease severity. Cholesterol‐lowering drugs, such as statins, are demonstrated to inhibit prostate cancer. VNPP433‐3β interrupts multiple signaling and metabolic pathways, including cholesterol biosynthesis, AR‐mediated transcription of several oncogenes, mRNA 5′
Retheesh S. Thankan+10 more
wiley +1 more source
Rapidity of hematoma resolution after fibrinolytic therapy for intracerebral hemorrhage has a favorable effect on functional outcome. [PDF]
Malinova V+4 more
europepmc +1 more source
Low expression of five purine metabolism‐related genes (ADSL, APRT, ADCY3, NME3, NME6) was correlated with poor survival in colorectal cancer. Immunohistochemistry analysis showed that low NME3 (early stage) and low ADSL/NME6 (late stage) levels were associated with high risk.
Sungyeon Kim+8 more
wiley +1 more source
Which outcomes should be included in a core outcome set for capturing and measuring doctor well-being? A Delphi study. [PDF]
Simons G, Klepacz N, Baldwin DS.
europepmc +1 more source